GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » EV-to-Revenue

Uni-Bio Science Group (HKSE:00690) EV-to-Revenue : 0.70 (As of Jun. 22, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Uni-Bio Science Group's enterprise value is HK$340.0 Mil. Uni-Bio Science Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$484.7 Mil. Therefore, Uni-Bio Science Group's EV-to-Revenue for today is 0.70.

The historical rank and industry rank for Uni-Bio Science Group's EV-to-Revenue or its related term are showing as below:

HKSE:00690' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.46   Med: 3.74   Max: 10.31
Current: 0.7

During the past 13 years, the highest EV-to-Revenue of Uni-Bio Science Group was 10.31. The lowest was 0.46. And the median was 3.74.

HKSE:00690's EV-to-Revenue is ranked better than
89.17% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs HKSE:00690: 0.70

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-22), Uni-Bio Science Group's stock price is HK$0.067. Uni-Bio Science Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.08. Therefore, Uni-Bio Science Group's PS Ratio for today is 0.88.


Uni-Bio Science Group EV-to-Revenue Historical Data

The historical data trend for Uni-Bio Science Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uni-Bio Science Group EV-to-Revenue Chart

Uni-Bio Science Group Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.49 3.24 1.29 0.87 0.78

Uni-Bio Science Group Semi-Annual Data
Mar14 Sep14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 - 0.87 - 0.78

Competitive Comparison of Uni-Bio Science Group's EV-to-Revenue

For the Biotechnology subindustry, Uni-Bio Science Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uni-Bio Science Group's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Uni-Bio Science Group's EV-to-Revenue falls into.



Uni-Bio Science Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Uni-Bio Science Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=340.023/484.718
=0.70

Uni-Bio Science Group's current Enterprise Value is HK$340.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uni-Bio Science Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$484.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Uni-Bio Science Group  (HKSE:00690) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Uni-Bio Science Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.067/0.076
=0.88

Uni-Bio Science Group's share price for today is HK$0.067.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Uni-Bio Science Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Uni-Bio Science Group (HKSE:00690) Business Description

Traded in Other Exchanges
N/A
Address
No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Executives
Automatic Result Limited
Mjkpc Holdings Limited
Leung Kingsley
Century Ally Ventures Limited 2201 Interest of corporation controlled by you
Fih (bvi) Limited 2201 Interest of corporation controlled by you
Petite Arbre Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Xjg Capital Management Limited 2201 Interest of corporation controlled by you
Yau Kwok Wing Tony 2201 Interest of corporation controlled by you
Lau Kan Sum 2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited 2301 Trustee
Mjkpc Holdings Limited 2201 Interest of corporation controlled by you

Uni-Bio Science Group (HKSE:00690) Headlines

No Headlines